Company Filing History:
Years Active: 2021
Title: Seyoung Lim: Innovator in Therapeutic Protein Development
Introduction
Seyoung Lim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of therapeutic proteins, particularly in the development of fusion proteins aimed at treating various metabolic diseases. With a total of 2 patents, his work is paving the way for innovative treatments in the medical field.
Latest Patents
Seyoung Lim's latest patents include "Long-acting FGF21 fusion proteins and pharmaceutical composition comprising same" and "Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising same." The first patent presents a fusion protein that combines an FGF21 mutant protein with an Fc region of an immunoglobulin. This fusion protein demonstrates improved pharmacological efficacy, in vivo duration, and protein stability. It is designed to be an effective therapeutic agent for conditions such as diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. The second patent introduces a dual function protein that links a biologically active protein with an FGF mutant protein, also attached to an Fc region of an immunoglobulin. This innovation similarly shows enhanced pharmacological efficacy and stability, making it a promising candidate for treating a range of metabolic and cardiovascular diseases.
Career Highlights
Seyoung Lim is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation focuses on advancing therapeutic solutions that address critical health issues. His innovative approach and dedication to research have positioned him as a key player in the field of biotechnology.
Collaborations
Seyoung Lim collaborates with talented professionals in his field, including Jun Hwan Kim and Minji Seo. Their combined expertise fosters a dynamic research environment that enhances the development of groundbreaking therapeutic proteins.
Conclusion
Seyoung Lim's contributions to the field of therapeutic proteins are noteworthy, with his innovative patents addressing significant health challenges. His work at Yuhan Corporation and collaborations with skilled colleagues further amplify his impact in the biotechnology sector.